It suggests that the benefits of managing seizures outweigh the downsides of memory problems. It may be that people can learn to compensate for memory problems easier and effectively, such as for example by making lists and using an electronic organizer, than they can compensate for the limitations that seizures can cause, such as for example not having the ability to get. Related StoriesPatients with Down syndrome face additional challenge of early-onset dementiaMisleading symptoms confuse management of older individuals with post-HSE relapseArticle explores viewpoints on role of slight cognitive impairment in Parkinson's diseaseLangfitt also noted that seizures are much less socially accepted than these kinds of memory problems probably, which he says patients can pass off as everyday forgetfulness sometimes.Extra data on adverse occasions in this study are given in the Supplementary Appendix. The incidences of adverse events through the induction period and the entire treatment period in the FIXTURE study were similar in the secukinumab and etanercept groups . The most typical adverse occasions in the secukinumab organizations during induction and the complete treatment period were nasopharyngitis, headache, and diarrhea. The incidence of injection-site reactions through the entire research was low in the combined secukinumab organizations than in the etanercept group , although the difference was not assessed for significance. The proportions of patients in the FIXTURE study who had infections and infestations through the induction period were 26.7 percent with the 300-mg dose of secukinumab, 30.9 percent with the 150-mg dose of secukinumab, 24.5 percent with etanercept, and 19.3 percent with placebo .